Buch, Englisch, 364 Seiten, Previously published in hardcover, Format (B × H): 178 mm x 254 mm, Gewicht: 7896 g
Reihe: Hematologic Malignancies
Buch, Englisch, 364 Seiten, Previously published in hardcover, Format (B × H): 178 mm x 254 mm, Gewicht: 7896 g
Reihe: Hematologic Malignancies
ISBN: 978-3-662-50772-8
Verlag: Springer
After a decade of tremendous progress in the diagnostic and therapeutic approaches to malignant lymphoma, optimal treatment strategies are now based not only on accurate diagnosis but also on thorough evaluation of clinical and molecular risk factors. Even more importantly, molecular targeted approaches have been shown to be effective in the treatment of distinct lymphoma subtypes. Against this background, clinical management of especially the rare lymphomas remains a challenge for the general oncologist. This book provides a comprehensive overview of current treatment strategies in these rare lymphoma subtypes. Experts in the field from around the world describe histomorphology in a clinically relevant manner, consider the role of risk factors in detail, and discuss the spectrum of therapeutic approaches. Special emphasis is placed on the translation of molecular science into clinical care, and a disease-specific algorithm is proposed for each entity.
Zielgruppe
Professional/practitioner
Autoren/Hrsg.
Fachgebiete
- Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Vorklinische Medizin: Grundlagenfächer Molekulare Medizin, Zellbiologie
- Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Klinische und Innere Medizin Innere Medizin
- Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Medizinische Fachgebiete Pathologie, Cytopathologie, Histopathologie
Weitere Infos & Material
I General: Pathology.- Cytogenetics.- Molecular Genetics.- Signal Pathways.- II Disease-specific: T-NHL: Acute T-cell leukemia.- Anaplastic lymphoma.- Nasal/NK-cell lymphoma.- Cutaneous T-cell lymphoma.- B-NHL: Adult Burkitt.- Primary Mediastinal Lymphoma.- CNS Lymphoma.- HIV-Associated lymphoma.- Marginal Zone Lymphoma.- MALT.- MCL.- Waldenstroem.- PLL.- Llymphocyte Predominant Hodgkin.- Cutaneous B-cell lymphoma.
